Market closed
Q32 Bio/$QTTB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Q32 Bio
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
Ticker
$QTTB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
43
Website
Q32 Bio Metrics
BasicAdvanced
$19M
-
-$4.93
-
-
Price and volume
Market cap
$19M
52-week high
$48.00
52-week low
$1.38
Average daily volume
213K
Financial strength
Current ratio
4.708
Quick ratio
4.492
Long term debt to equity
-336.472
Total debt to equity
-500.947
Interest coverage (TTM)
-45.35%
Management effectiveness
Return on assets (TTM)
-34.29%
Return on equity (TTM)
-267.20%
Valuation
Price to book
-4.68
Price to tangible book (TTM)
-4.68
Price to free cash flow (TTM)
-0.284
Growth
Earnings per share change (TTM)
-95.91%
What the Analysts think about Q32 Bio
Analyst Ratings
Majority rating from 3 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Q32 Bio stock?
Q32 Bio (QTTB) has a market cap of $19M as of May 09, 2025.
What is the P/E ratio for Q32 Bio stock?
The price to earnings (P/E) ratio for Q32 Bio (QTTB) stock is 0 as of May 09, 2025.
Does Q32 Bio stock pay dividends?
No, Q32 Bio (QTTB) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Q32 Bio dividend payment date?
Q32 Bio (QTTB) stock does not pay dividends to its shareholders.
What is the beta indicator for Q32 Bio?
Q32 Bio (QTTB) does not currently have a Beta indicator.